Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi

R W Redline1, A Pappin

  • 1Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.

Human Pathology
|January 1, 1995
PubMed

Thrombosis of large fetal vessels in the placenta leads to regions of downstream avascular villi (AV). Avascular villi have been associated with adverse outcomes in anecdotal reports, but no controlled study of their significance has been done. We prospectively gathered cases of extensive AV (n = 29) occurring over a 2-year period at the Institute of Pathology at Case Western Reserve University and compared obstetric history, coexistent placental pathology, and neonatal outcome to gestational age-matched controls in a case control study. The diagnosis of extensive AV required one or more of the following characteristics: 2.5% or more of total villous parenchyma affected, foci in multiple sections, or a single lesion measuring 0.25 cm2 or larger. Women with AV placentas had increased rates of intrauterine growth retardation (IUGR), acute and chronic monitoring abnormalities, oligohydramnios, and maternal coagulation disorders. Placentas with AV were more likely to have coexistent chronic villitis, membrane hemosiderin, meconium in all three membrane layers, and villous chorangiosis. Finally, among the subgroup of neonates older than 34 weeks gestation without congenital malformations or coexistent placental pathology (n = 18), we identified significant abnormalities, including major thrombotic events (n = 5), neonatal death (n = 2), umbilical artery pH less than 7.10 (n = 4), platelet count less than 150,000 (n = 4), increased nucleated red blood cell (NRBC) counts (n = 7), and transient hypoglycemia (n = 4). Placental features correlating with clinical abnormalities included percentage of greater than 30% AV, recent platelet and fibrin aggregates, and multifocal disease involving more than one histological section.

Related Concept Videos

Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...